Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
gptkb:VEGF_Trap-Eye
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:developedBy |
gptkb:Allergan
gptkb:Santen_Pharmaceutical |
| https://www.w3.org/2000/01/rdf-schema#label |
somavaratan
|
| gptkbp:intendedUse |
treatment of wet age-related macular degeneration
|
| gptkbp:mechanismOfAction |
VEGF inhibitor
|
| gptkbp:routeOfAdministration |
intravitreal injection
|
| gptkbp:status |
development discontinued
|
| gptkbp:target |
gptkb:vascular_endothelial_growth_factor_(VEGF)
|
| gptkbp:bfsParent |
gptkb:Versartis
|
| gptkbp:bfsLayer |
7
|